Business Wire

1954 Ferrari 750 Monza Wins the Peninsula Classics 2020 Best of the Best Award

9.2.2021 09:00:00 EET | Business Wire | Press release

Share

The Peninsula Hotels, whose international hospitality brand has epitomised glamour and luxury for nearly a century, today announced the winner of its sixth annual classic car showcase, The Peninsula Classics 2020 Best of the Best Award. The winning car, the 1954 Ferrari 750 Monza, coachwork by Scaglietti, has achieved distinction both for its impressive racing history and its exacting restoration. It became eligible as a Best of the Best Award contender after winning Best of Show at the 2020 Palm Beach Cavallino Classic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005295/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

1954 Ferrari 750 Monza wins The Peninsula Classics 2020 Best of the Best Award (Photo Copyright: Jay Miller)

The Best of the Best Award was co-founded in 2015 by The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited (owner and operator of The Peninsula Hotels), along with William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. The Award celebrates the fine engineering and design of classic cars built by internationally renowned manufacturers, selected from an exceptional short list of winners from the most exclusive concours. This year’s award has a contracted list of nominees due to cancellation or postponement of partner concours in 2020 as a result of the COVID-19.

The 1954 Ferrari 750 Monza was chosen from a selection of four nominees crafted by automakers from Italy, Germany, and the United States, including a 1969 Porsche 917 KH Coupé, coachwork by the Factory, 2020 Best of Show, Concours of Elegance Hampton Court Palace, 1931 Alfa Romeo 8C 2300 Monza Spider, coachwork by Zagato, 2020 Best of Show, Salon Privé and a 1929 Duesenberg Model J Town Limousine, coachwork by Murphy, 2020 Best of Show, Amelia Island Concours d’Elegance.

The winner was selected by The Best of the Best Award’s esteemed panel of judges, including, amongst others, designers Gordon Murray (former Formula 1 designer for Brabham and McLaren) and Anne Asensio (Vice President of Design Experience at Dassault Systèmes), and prominent classic car collectors Laurence Graff and Jay Leno.

“It was a difficult task for our judges to select a winner this year. Our judging procedures had to be carried out remotely and unfortunately the main awards event had to be cancelled, with social distancing measures and safety our top priority,” said The Hon. Sir Michael Kadoorie. “With such a prestigious collection of nominees, choosing one winner was especially challenging. However, it is always a great pleasure to spotlight the remarkable achievements of the automotive industry, and to create a small spark of joy in the current challenging times. These classic vehicles are an enduring testament to human artistry and ingenuity.”

The winning 750 Monza made its original debut with a 2-litre motor at the Inaugural Grand Prix of the Imola Autodrome in June of 1954. After driver Umberto Maglioli secured first place for Scuderia Ferrari with the car, it was subsequently fitted with a 3-litre engine and went on to compete in several other major races that year, including the Monsanto Grand Prix (where it won), and Nassau Race Week – where it was driven by its original owner, Alfonso de Portago, and secured a 1st and two 2nd places.

The car’s next owner, Sterling Edwards, raced the 750 Monza over the next two years mainly in California, including the Pebble Beach Road Races (an event he founded) in 1955 and 1956 – garnering four 1st-place and two first-in-class wins in the car. After the tragic death of his friend Ernie McAfee prompted Edwards to stop racing altogether, he sold the car to his engineer Bob Whitmer, who replaced its engine with a Chevy V8 and continued to successfully race it through the early 1960s.

The car spent most of the ensuing 50 years disassembled, though its chassis, body, engine, and gearbox were all carefully preserved in a small San Francisco-area warehouse. In 2016, a complete restoration of the car was initiated under the direction of Bob Smith Coachworks, located in Gainesville, Texas, a process that took new owners Tom and Jill Peck of southern California over two years to complete.

The refurbishment was guided by several noted Ferrari historians: Marcel Massini of Switzerland, Alan Boe of Braselton, Georgia, David Seielstad of Hawaii, as well as past owners Sterling Edwards’ son Hammond and Bob Whitmer, both from northern California. The vintage certification team at Ferrari Classiche in Maranello, Italy, was also helpful in piecing together the early racing career of the car while campaigned by Ferrari. Bringing their combined wealth of knowledge to the project, these experts employed many of the vehicle’s preserved original documents and instruments, including the original owners’ manual, toolboxes, build sheets, and a treasure trove of original photographs of the car. Computer modelling of these photos was employed to repair flaws in the body from the car’s racing days, and 3-D printing technology was utilised to duplicate some parts that were irreparable. The vehicle’s livery was restored to that which it sported in its first Carrera Panamericana race in 1954.

Once fully restored, the 1954 Ferrari 750 Monza won the Enzo Ferrari Award at the 2019 Pebble Beach Concours d’Elegance and 2020 Best of Show at the Cavallino Classic, before being named winner of The Peninsula Classics 2020 Best of the Best Award.

“It is a true honour to be recognised by the venerable judges of The Peninsula Classics,” said Mr. Peck of his car’s latest success. “Like so many classic cars, this one has been both a labour of love and the product of dedicated teamwork. The Best of the Best Award is a crowning achievement for everyone involved.”

About The Peninsula Classics Best of the Best Award

Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motor cars, the preservation of their heritage and immaculate restoration projects. The award, sponsored by The Peninsula Hotels, brings together elite ‘Best of Show’ winners from nine of the renown concours circuits around the globe: Amelia Island Concours d’Elegance, Cavallino Classic, Chantilly Arts & Elegance Richard Mille, Concorso d’Eleganza Villa d’Este, Concours of Elegance Hampton Court Palace, Goodwood Cartier Style et Luxe Concours d’Elegance, Pebble Beach Concours d’Elegance, Salon Privé, and The Quail, A Motorsports Gathering.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact
Denis Brunet
Senior Manager, Brand Marketing & Communications
The Peninsula Hotels
Telephone: +852 2840 7275
E-mail: denisbrunet@peninsula.com
Newsroom: www.peninsula.com/en/newsroom
Website: www.peninsula.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye